Handling missing values in cost effectiveness analyses that use data from cluster randomized trials

Journal of the Royal Statistical Society. Series A: Statistics in Society

Volumn 177, Issue 2, 2014, Pages 457-474

  Diaz Ordaz K ^a   Kenward, Michael G ^a   Grieve, Richard ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Bivariate models; Clustered continuous data; Cost effectiveness; Missing data; Multiple imputation

Indexed keywords

EID: 84893806570     PISSN: 09641998     EISSN: 1467985X     Source Type: Journal    
DOI: 10.1111/rssa.12016     Document Type: Article

References (63)

1. Andridge, R. R. (2011) Quantifying the impact of fixed effects modeling of clusters in multiple imputation for cluster randomized trials. Biometr. J., 53, 57-74.
2. Bachmann, M. O., Fairall, L., Clark, A. and Mugford, M. (2007) Methods for analyzing cost effectiveness data from cluster randomized trials. Cost Effectiv. Resrce Allocn, 5, paper 12.
3. Basu, A. and Manca, A. (2012) Regression estimators for generic health-related quality of life and quality-adjusted life years. Med. Decsn Makng, 32, 56-69.
4. Blough, D. K., Ramsey, S. D., Sullivan, S. D. and Yusen, Y., for the NETT Research Group (2009) The impact of using different imputation methods for missing quality of life scores on the estimation of the cost-effectiveness of lung volume-reduction surgery. Hlth Econ., 18, 91-101.
5. Briggs, A., Clark, T., Wolstenholme, J. and Clarke, P. (2003) Missing presumed at random: cost-analysis of incomplete data. Hlth Econ., 12, 377-392.
6. Briggs, A. and Gray, A. (1998) The distribution of health care costs and their statistical analysis for economic evaluation. J. Hlth Serv. Res. Poly, 3, 233-245.
7. Campbell, M. K., Mollison, J., Steen, N., Grimshaw, J. M. and Eccles, M. (2000) Analysis of cluster randomized trials in primary care: a practical approach. Famly Pract., 17, 192-196.
8. Canadian Agency for Drugs and Technologies in Health (2006) Guidelines for the Economic Evaluation of Health Technologies. Ottawa: Canadian Agency for Drugs and Technologies in Health.
9. Carpenter, J. R. and Goldstein, H. (2004) Multiple imputation in MLwiN. Multilev. Modllng Newslett., 16, 9-18.
10. Carpenter, J. R., Goldstein, H. and Kenward, M. G. (2011) REALCOM-IMPUTE software for multilevel multiple imputation with mixed response types. J. Statist. Softwr., 45, 1-14.
11. Carpenter, J. R., Kenward, M. G. and White, I. R. (2007) Sensitivity analysis after multiple imputation under missing at random: a weighting approach. Statist. Meth. Med. Res., 16, 259-275.
12. Duan, N. (1983) Smearing estimate: a nonparametric retransformation method. J. Am. Statist. Ass., 78, 605-610.
13. Eldridge, S. and Kerry, S. (2012) A Practical Guide to Cluster Randomised Trials in Health Services Research. Chichester: Wiley-Blackwell.
14. Flynn, T. N. and Peters, T. J. (2005) Cluster randomized trials: another problem for cost-effectiveness ratios. Int. J. Technol. Assessmnt Hlth Care, 21, 403-409.
15. Glick, H. A., Doshi, J., Sonnad, S. and Polsky, D. (2007) Economic Evaluation in Clinical Trials. Oxford: Oxford University Press.
16. Gold, M., Siegel, J., Russell, L. and Weinstein, M. (eds) (1996) Cost-effectiveness in Health and Medicine. Oxford: Oxford University Press.
17. Goldstein, H. (2011) Multilevel Statistical Models, 4th edn. Chichester: Wiley.
18. Gomes, M., Grieve, R., Edmunds, J. and Nixon, R. (2012a) Statistical methods for cost-effectiveness analyses that use data from cluster randomised trials: a systematic review and checklist for critical appraisal. Med. Decsn Makng, 32, 209-220.
19. Gomes, M., Ng, E. S., Grieve, R., Nixon, R., Carpenter, J. R. and Thompson, S. G. (2012b) Developing appropriate analytical methods for cost-effectiveness analyses that use cluster randomized trials. Med. Decsn Makng, 32, 350-361.
20. Graham, J. W. (2009) Missing data analysis: making it work in the real world. A. Rev. Psychol., 60, 549-576.
21. Gray, A., Clarke, P., Wolstenholme, J. and Wordsworth, S. (2010) Applied Methods of Cost-effectiveness Analysis in Healthcare. Oxford: Oxford University Press.
22. Grieve, R., Nixon, R. and Thompson, S. G. (2010) Bayesian hierarchical models for cost-effectiveness analyses that use data from cluster randomized trials. Med. Decsn Makng, 30, 163-175.
23. Hayes, R. and Moulton, L. (2009) Cluster Randomised Trials. Boca Raton: Chapman and Hall-CRC.
24. Jones, A. and Rice, N. (2011) Econometric Evaluation of Health Policies. Oxford: Oxford University Press.
25. Kaambwa, B., Bryan, S. and Billingham, L. (2012) Do the methods used to analyse missing data really matter?: an examination of data from an observational study of Intermediate Care patients. BMC Res. Notes, 5, 330-350.
26. Kenward, M. G. and Carpenter, J. R. (2007) Multiple imputation: current perspectives. Statist. Meth. Med. Res., 16, 199-218.
27. Lambert, P., Sutton, A., Burton, P., Abrams, K. and Jones, D. (2005) How vague is vague?: a simulation study of the impact of the use of vague prior distributions in MCMC using WinBUGS. Statist. Med., 24, 2401-2428.
28. Little, R. J. A. and Rubin, D. B. (2002) Statistical Analysis with Missing Data, 2nd edn. Chichester: Wiley.
29. Manca, A., Rice, N., Sculpher, M. J. and Briggs, A. (2005) Assessing generalisability by location in trial-based cost-effectiveness analysis: the use of multilevel models. Hlth Econ., 14, 471-485.
30. Manning, W. G. (1998) The logged dependent variable, heteroscedasticity, and the retransformation problem. J. Hlth Econ., 17, 283-295.
31. Manning, W. (2006) Dealing with skewed data on costs and expenditures. In The Elgar Companion to Health Economics, ch. 44. Cheltenham: Elgar.
32. Manning, W. G. and Mullahy, J. (2001) Estimating log models: to transform or not to transform? J. Hlth Econ., 20, 461-494.
33. Mason, A., Richardson, S., Plewis, I. and Best, N. (2012) Strategy for modelling non-random missing data mechanisms in observational studies using Bayesian methods. J. Off. Statist., 28, 279-302.
34. Molenberghs, G. and Kenward, M. G. (2007) Missing Data in Clinical Studies. Chichester: Wiley.
35. Morrell, C. J., Slade, P., Warner, R., Dixon, S., Nicholl, J., Walters, S. J., Brugha, T., Barkham, M. and Parry, G. (2009) Clinical effectiveness of health visitor training in psychologically informed approaches for depression in postnatal women: pragmatic cluster randomised trial in primary care. Br. Med. J., 338, article a3045.
36. Morrell, C. J., Warner, R., Slade, P., Dixon, S., Walters, S. J., Paley, G. and Brugha, T. (2009b). Psychological interventions for postnatal depression: cluster randomised trial and economic evaluation. the PoNDER trial. Hlth Technol. Assessmnt, 13, 1-153.
37. Mullahy, J. (1998) Much ado about two: reconsidering retransformation and the two-part model in health econometrics. J. Hlth Econ., 17, 247-281.
38. National Institute for Health and Clinical Excellence (2008) Guide to the Methods for Technology Appraisal. London: National Institute for Health and Clinical Excellence.
39. Neuhaus, J. M. and McCulloch, C. E. (2011) Estimation of covariate effects in generalized linear mixed models with informative cluster sizes. Biometrika, 98, 147-162.
40. Nixon, R. M. and Thompson, S. G. (2005) Methods for incorporating covariate adjustment, subgroup analysis and between-centre differences into cost-effectiveness evaluations. Hlth Econ., 14, 1217-1229.
41. Noble, S., Hollingworth, W. and Tilling, K. (2012) Missing data in trial-based cost-effectiveness analysis: the current state of play. Hlth Econ., 21, 187-200.
42. O'Hagan, A. and Stevens, J. W. (2001) A framework for cost-effectiveness analysis from clinical trial data. Hlth Econ., 10, 303-315.
43. O'Hagan, A. Stevens, J. W. and Montmartin, J. (2001) Bayesian cost-effectiveness analysis from clinical trial data. Statist. Med., 20, 733-753.
44. Omar, R. Z. and Thompson, S. G. (2000) Analysis of a cluster randomized trial with binary outcome data using a multi-level model. Statist. Med., 19, 2675-2688.
45. Oostenbrink, J. B. and Al, M. J. (2005) The analysis of incomplete cost data due to dropout. Hlth Econ., 14, 763-776.
46. Pharmaceutical Benefits Advisory Committee (2008) Guidelines for Preparing Submissions to the Pharmaceutical Benefits Advisory Committee. Camberra: Australian Government.
47. Pinto, E. M., Willan, A. R. and O'Brien, B. J. (2005) Cost-effectiveness analysis for multinational clinical trials. Statist. Med., 24, 1965-1982.
48. Ramsey, S., Willke, R. and Briggs, A. (2005) Good research practices for cost-effectiveness analysis alongside clinical trials: the ISPOR RCT-CEA task force report. Val. Hlth, 8, 521-533.
49. Rasbash, J., Charlton, C., Browne, W., Healy, M. and Cameron, B. (2011) MLwiN version 2.23. Centre for Multilevel Modelling, University of Bristol, Bristol. (Available from http://www.bristol.ac.uk/cmm/.)
50. R Development Core Team (2011) The R project for statistical computing. R Development Core Team, Vienna. (Available from http://www.Rproject.org/.)
51. Rubin, D. (1976) Inference and missing data. Biometrika, 63, 581-592.
52. Rubin, D. (1978) Multiple imputations in sample surveys-a phenomenological Bayesian approach to non response. Proc. Surv. Res. Meth. Sect. Am. Statist. Ass., 18, 20-34.
53. Rubin, D. (1987) Multiple Imputation for Nonresponse in Surveys. New York: Wiley.
54. Schafer, J. (1997) Analysis of Incomplete Multivariate Data. London: Chapman and Hall.
55. Schafer, J. and Yucel, R. (2002) Computational strategies for multivariate linear mixed-effects models with missing values. J. Computnl Graph. Statist., 11, 421-442.
56. Taljaard, M., Donner, A. and Klar, N. (2008) Imputation strategies for missing continuous outcomes in cluster randomized trials. Biometr. J., 50, 329-345.
57. Thompson, S. G. and Nixon, R. M. (2005) How sensitive are cost-effectiveness analyses to choice of parametric distributions? Med. Decsn Makng, 25, 416-423.
58. Welton, N. J., Ades, A. E., Caldwell, D. M. and Peters, T. J. (2008) Research prioritization based on expected value of partial perfect information: a case-study on interventions to increase uptake of breast cancer screening (with discussion). J. R. Statist. Soc. A, 171, 807-841.
59. White, I. R., Royston, P. and Wood, A. M. (2011) Multiple imputation using chained equations: issues and guidance for practice. Statist. Med., 30, 377-399.
60. Willan, A. (2006) Statistical Analysis of cost-effectiveness data from randomised clinical trials. Exprt Revisn Pharmecon. Outcms Res., 6, 337-346.
61. Willan, A. and Briggs, A. (2006) Statistical Analysis of Cost-effectiveness Data. Chichester: Wiley.
62. Willan, A. R., Chen, E., Cook, R. and Lin, D. (2003) Incremental net benefit in randomized clinical trials with quality-adjusted survival. Statist. Med., 22, 353-362.
63. Yucel, R. and Dermitas, H. (2010) Impact of non-normal random effects on inference by multiple imputation: a simulation assessment. Computnl Statist. Data Anal., 54, 790-801.